New trends in the development of opioid peptide analogues as advanced remedies for pain relief.
The search for new peptides to be used as analgesics in place of morphine has been mainly directed to develop peptide analogues or peptidomimetics having higher biological stability and receptor selectivity. Indeed, most of the alkaloid opioid counterindications are due to the scarce stability and the contemporary activation of different receptor types. However, the development of several extremely stable and selective peptide ligands for the different opioid receptors, and the recent discovery of the micro-receptor selective endomorphins, rendered this search less fundamental. In recent years, other opioid peptide properties have been investigated in the search for new pharmacological tools. The utility of a drug depends on its ability to reach appropriate receptors at the target tissue and to remain metabolically stable in order to produce the desired effect. This review deals with the recent investigations on peptide bioavailability, in particular barrier penetration and resistance against enzymatic degradation; with the development of peptides having activity at different receptors; with chimeric peptides, with propeptides, and with non-conventional peptides, lacking basic pharmacophoric features.
Gentilucci
Luca
L
Dipartimento di Chimica "G. Ciamician", via Selmi 2, Università degli Studi di Bologna, 40126-Bologna, Italy. gentil@ciam.unibo.it
D000596:Amino Acids / Q000737:chemistry; D000701:Analgesics, Opioid / Q000737:chemistry* / Q000378:metabolism / Q000494:pharmacology; D000818:Animals; D001665:Binding Sites; D001921:Brain / Q000378:metabolism; D019281:Dimerization; D015195:Drug Design; D004355:Drug Stability; D006801:Humans; D018847:Opioid Peptides / Q000737:chemistry* / Q000378:metabolism; D010447:Peptide Hydrolases / Q000737:chemistry / Q000378:metabolism; D010456:Peptides, Cyclic / Q000737:chemistry / Q000378:metabolism; D011355:Prodrugs / Q000737:chemistry / Q000378:metabolism; D011487:Protein Conformation; D011957:Receptors, Opioid / Q000145:classification / Q000187:drug effects / Q000378:metabolism; D013329:Structure-Activity Relationship
D000596:Amino Acids; D000701:Analgesics, Opioid; D018847:Opioid Peptides; D010456:Peptides, Cyclic; D011355:Prodrugs; D011957:Receptors, Opioid; D010447:Peptide Hydrolases